Does a data license need board approval at a PE-backed company?

The short answer for a portfolio CFO

Often yes, but the company's own documents decide, not a general rule. At a PE-backed company a data licensing agreement can trigger three separate approvals: the board under the delegation of authority, the sponsor under consent rights in the stockholders or LLC agreement, and the lenders under the credit agreement. Find all three before the term sheet, because each one can add a meeting to the calendar.

An exclusive license of company data is not routine purchasing. It grants rights over a company asset for a term, may restrict future uses and touches privacy commitments, so many CFOs take it to the board even where no document strictly requires it.

Where does approval authority usually sit?

Read the definitions in each document. Whether the material-contract or disposition definitions capture a data license depends on the drafting, and the answer at one portfolio company says nothing about the next.

What do the outside rules add?

Two external rules shape the board's questions even though neither requires approval itself.

Revenue recognition. Under ASC 606, a license of intellectual property is either a right to use the IP as it exists when granted, recognized at a point in time, or a right to access it throughout the license period, recognized over time. Deloitte's roadmap chapter on identifying the nature of a license sets out the analysis. How a particular data license is accounted for is a question for the company's auditors, and the board will want that answer before it approves a price.

Customer commitments. In January 2024 FTC staff wrote that companies' promises not to use customer data for undisclosed purposes, such as training models, are enforceable whether they appear in privacy policies, terms of service or marketing, in a post titled AI companies: uphold your privacy and confidentiality commitments. Staff posts are not rules, yet this one explains why the board memo should show what the company promised customers. The page on why data rights determine what a company can license gives the wider context.

What will the board ask, and what should the memo say?

A sequence that avoids a second board meeting

1. Map approvals: the CFO and general counsel list every consent from the first table that applies to this company.
2. Brief the sponsor's deal partner informally before anything goes to the full board.
3. Check whether lender consent is needed and, if so, start the request early.
4. Complete the data inventory so the scope in the memo is concrete.
5. Agree the de-identification and redaction requirements with SourceX before any work begins.
6. Circulate the memo with the draft terms, the rights review and the auditor view.
7. Pass a resolution that authorizes a named officer to sign within set parameters.
8. Report back to the board after signing and again when payment arrives.

An illustrative parameters resolution, to adapt with counsel:

Questions to ask counsel before the meeting

• Does any sponsor consent right, reserved matter or credit agreement covenant capture an exclusive data license at this company?
• Do customer contracts or privacy notices restrict the planned use, and do any customers need to consent? Start with whether customer consent is needed.
• Does the license conflict with an existing exclusivity or confidentiality obligation?
• What assignment and change-of-control terms would a future acquirer expect to see?
• Is this a company that should not license at all? The list of portfolio companies that are not a fit is a quick cross-check.

This is general information, not legal, tax or financial advice. Confirm with your own counsel, auditors and lenders before acting.

Where introductions and partner rewards fit

Approvals happen after the introduction, inside the company, working with SourceX. A partner, whether an operating partner, a CFO peer or an advisor, only makes the introduction and never handles records. The board keeps full control: there is no commitment until the company accepts the price and terms and signs. If you would introduce a company you work for or sit on the board of, disclose the referral relationship to the board and follow its conflicts policy before you register.

Partners earn 25% of the eligible platform fees SourceX actually collects from the referred company's licensing deals, capped at $100,000 per referred company. The reward becomes payable only after the buyer pays and SourceX receives its fee, and it is never deducted from what the company receives. Sponsors with exited companies should read introducing a company after exit, and operating teams will find the screening approach on the private equity operating partners page.

Next step

Share this page with the general counsel before the first board conversation. To introduce a company, register as a partner; the company itself can apply at sourcex.si/apply.